Table 3.
Outcome measures used in published studies of multi-day rTMS applied to primary motor cortex to treat chronic neuropathic pain
| Study (see references below) | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| General Pain | |||||||||||||||
|
| |||||||||||||||
| Numeric Pain Rating Scale (NPRS) | X | X | X | ||||||||||||
| Visual Analogue Scale (VAS) for pain | X | X | X | X | X | X | X | X | X | X | |||||
| Brief Pain Inventory (BPI) | X | X | X | ||||||||||||
| McGill Pain Questionnaire (MPQ) | X | X | X | X | |||||||||||
| Short form McGill Pain Questionnaire (SF-MPQ) | X | ||||||||||||||
| Brazilian Profile of Chronic Pain: Screen (B-PCP:S) | X | ||||||||||||||
| Pain Impact questionnaire (PIQ-6) | X | ||||||||||||||
|
| |||||||||||||||
| Neuropathic Pain | |||||||||||||||
| Douleur Neuropathique en 4 Questions (DN4) | X | X | |||||||||||||
| Neuropathic Pain Symptom Inventory (NPSI) | X | ||||||||||||||
| The Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) | X | X | |||||||||||||
|
| |||||||||||||||
| Depression/Anxiety | |||||||||||||||
| Beck Depression Inventory (BDI) | X | X | X | X | X | X | X | X | |||||||
| Hamilton Depression Rating Scale (HDRS) | X | X | |||||||||||||
| Hospital Anxiety and Depression Scale (HAD) | X | X | X | ||||||||||||
| Hamilton Anxiety Rating Scale (HARS) | X | ||||||||||||||
| State-Trait Anxiety Inventory (STAI) | X | ||||||||||||||
| Pain Catastrophizing Scale (PCS) | X | X | |||||||||||||
|
| |||||||||||||||
| Disability | |||||||||||||||
| Disabilities of the Arm, Shoulder and Hand (DASH) | X | ||||||||||||||
| The 36-Item Short Form Health Survey (SF-36) | X | X | X | ||||||||||||
|
| |||||||||||||||
| General | |||||||||||||||
| Linkert Scale (satisfaction with treatment) | X | ||||||||||||||
| Patient Global Impression of Change (PGIC) | X | X | |||||||||||||
|
| |||||||||||||||
| Sleep | |||||||||||||||
| Pittsburgh Sleep Quality Index (PSQI) | X | ||||||||||||||
|
| |||||||||||||||
| Disease Specific | |||||||||||||||
| Fibromyalgia Impact Questionnaire (FIQ) | X | X | X | X | |||||||||||
A: Khedr et al., JNNP 2005 [52]. B: Passard et al., Brain 2007 [94]. C: Defrin et al., Arch Phys Med Rehabil 2007 [26]. D: Kang et al., Arch PM&R 2009 [51]. E: Picarelli et al., J of Pain 2010 [98]. F: Mhalla et al., PAIN 2011 [78] G: Lee et al., Am J PM&R 2012 [57]. H: Lefaucheur et al., EJP 2012 [60]. I: Hosomi et al., PAIN 2013 [48]. J: Onesti et al., PAIN 2013 [90]. K: Fricová et al., Physiol. Res. 2013 [37]. L: Hasan et al., Neuromodulation Journal 2014 [45]. M: Dall’Agnol et al., J of Pain 2014 [22]. N: Boyer et al., Neurology 2014 [18]. O: Yýlmaz et al., J of Spinal Cord Medicine 2014 [122].